Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Regeneus Ltd. ( (AU:CMB) ) is now available.
Cambium Bio Limited, a company involved in biotechnology, has announced a change in its substantial holding. The company’s voting power has decreased from 20.7% to 13.5% due to a share consolidation and subsequent dilution following a share placement. This change in voting power could impact the company’s influence in decision-making and its strategic direction, affecting stakeholders’ interests.
More about Regeneus Ltd.
YTD Price Performance: -12.50%
Average Trading Volume: 23,974
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$6.4M
Learn more about CMB stock on TipRanks’ Stock Analysis page.